
Auteur D. KUSHLICK
|
Documents disponibles écrits par cet auteur (4)

This report is the culmination of over a decade's thinking and experience of campaigning for drug policy reform. This process has been informed recently by the 'Options for Control' seminar series held in conjunction with the Mannheim Centre for[...]
The government boasts of evidence-based policymaking, yet there seems to be little or no evidence available to support the current policy of prohibiting drugs. (Review' s abstract)
C. WILKINS, Auteur ; A. RITTER, Auteur du commentaire ; L. VON DIEMEN, Auteur du commentaire ; S. ROLLES, Auteur du commentaire ; D. KUSHLICK, Auteur du commentaire ; A. L. BRETTEVILLE-JENSEN, Auteur du commentaire ; B. HUGHES, Auteur du commentaire ; P. GRIFFITHS, Auteur du commentaire | 2014
Dans Addiction (Vol.109, n°10, October 2014) Article : PériodiqueBackground: New Zealand has recently attempted to address the underlying drivers of the escalating new psychoactive substances (NPS) ('legal highs') problem by establishing the world's first pre-market approval regulatory regime for NPS. NPS pro[...]
In April [2016], the world will come together at the UN to discuss the future of international drug policy. It will be the first time that far-reaching drug policy reforms are meaningfully discussed at such a high level. The current enforcement[...]